Current Guidelines for the Eradication of Helicobacter pylori in Peptic Ulcer Disease

Drugs

Volumn 50, Issue 6, 1995, Pages 984-990

  Rauws, Erik A J ^a   van der Hulst, René W M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; IMIDAZOLE; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE; TETRACYCLINE; TINIDAZOLE;

ANTIMICROBIAL THERAPY; BURNING MOUTH SYNDROME; CANDIDIASIS; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG EFFICACY; DUODENUM ULCER; HEADACHE; HELICOBACTER PYLORI; HUMAN; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PEPTIC ULCER; PRACTICE GUIDELINE; PSEUDOMEMBRANOUS COLITIS; RASH; RELAPSE; REVIEW; STOMACH ACID SECRETION; STOMACH ULCER; ULCER HEALING; VERTIGO;

ANTACIDS; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; COMPARATIVE STUDY; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRACTICE GUIDELINES;

EID: 0028841192     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-199550060-00006     Document Type: Article

References (44)

1. Campylobacter pyloritis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antimicrobial and antiulcer treatment
2. A study of the pathogenesis of Helicobacter pylori negative duodenal ulceration
3. Helicobacter pylori negative duodenal ulcer
4. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration
5. Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug-induced gastropathy
6. Campylobacter pylori, NSAIDs, and smoking: risk factors for peptic ulcer disease
7. Helicobacter pylori in peptic ulcer disease
8. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis
9. Therapeutic attempts at eradication of Campylobacter pylori
10. Drug therapy for Helicobacter-pylori infection: problems and pitfalls
11. Failure of azitromycin to eradicate Campylobacter pylori from the stomach because of required resistance during treatment
12. Helicobacter pylori therapy randomized study of denol/antibiotic combination
13. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies
14. Surveillance of Helicobacter pylori resistance to macrolides and nitro-imidazoles compounds at a national level [abstract no. 334]
15. Omeprazole plus amoxicillin for cure of H. Pylori infection. Factors influencing the treatment success
16. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients
17. Changes in the intragastric distribution of H.pylori during treatment with omeprazole
18. Review article: Helicobacter pylori eradication — understandable caution but no excuse for inertia
19. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori
20. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori
21. Effect of ranitidine and amoxycillin plus metronidazole on the eradication of H. pylori and the recurrence of duodenal ulcer
22. Effect of omeprazole and clarythromycin plus timidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer [abstract]
23. Helicobacter pylori eradication: efficacy and side-effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens
24. Optimal H. pylori therapy: a combination of omeprazole and triple therapy [abstract]
25. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection
26. Early relapse rate after healing of C. pylori-positive duodenal ulcers [abstract]
27. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate
28. Eradication of Campylobacter pylori: are we being misled? [letter]
29. Impact of metronidazole resistance on the eradication of Helicobacter pylori
30. Omeprazole, bismuth and clarithromycin: a new approach to the treatment of Helicobacter pylori (HP)-related gastritis [abstract]
31. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori
32. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori
33. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study
34. One weeks’s anti- Helicobacter pylori treatment for duodenal ulcer
35. Dual therapy with high dose of omeprazole versus triple therapy using omeprazole in combination with two antibiotics for H. pylori eradication [abstract]
36. Cure of duodenal ulcer after eradication of Helicobacter pylori
37. Spontaneous healing of duodenal ulcers after eradication H. pylori [abstract]
38. Helicobacter pylori treatment: double vs. triple therapy: who needs bismuth? [abstract]
39. One-week low dose triple therapy for the eradication of Helicobacter pylori infection
40. Eradication of Helicobacter pylori with clarithromycin and omeprazole
41. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomized controlled trial
42. Clinical course of duodenal ulcer disease: one year after omeprazole plus amoxycillin or triple therapy plus ranitidine for cure of Helicobacter pylori infection